Claudin-1 expression in epithelial skin tumor cells

Khlebnikova A.N.; Sedova T.G.; Gurevich L.E.; Selezneva E.V.; Molochkov A.V.

doi:https://doi.org/10.17116/klinderma20212001143

Khlebnikova A.N.

M.F. Vladimirsky Moscow Regional Research Clinical Institute

Scopus AuthorID: 6507373964
ORCID: 0000-0003-4400-5631

Sedova T.G.

E.A. Vagner Perm State Medical University

ORCID: 0000-0002-2660-0536

Gurevich L.E.

M.F. Vladimirsky Moscow Regional Research and Clinical Institute

Selezneva E.V.

M.F. Vladimirsky Moscow Regional Research and Clinical Institute

ORCID: 0000-0002-6181-9031

Molochkov A.V.

M.F. Vladimirsky Moscow Regional Research Clinical Institute;
Peoples’ Friendship University of Russia

Claudin-1 expression in epithelial skin tumor cells

Authors:

Khlebnikova A.N., Sedova T.G., Gurevich L.E., Selezneva E.V., Molochkov A.V.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2021;20(1): 43‑49

DOI: 10.17116/klinderma20212001143

Read: 2460 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Khlebnikova AN, Sedova TG, Gurevich LE, Selezneva EV, Molochkov AV. Claudin-1 expression in epithelial skin tumor cells. Russian Journal of Clinical Dermatology and Venereology. 2021;20(1):43‑49. (In Russ.)
https://doi.org/10.17116/klinderma20212001143

Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)

Использование инфографики авторами научных работ

Close metadata

ACTUALIZATION

Claudin-1 is a protein that is an integral part of the tight junctions of epidermal cells. Until the end, its role in the process of carcinogenesis is not clear. In colorectal and breast cancer cells, the appearance of pathological expression of claudin-1 or its complete loss was noted, which is associated. The appearance of a clear expression in the cells of the invasive front of cervical cancer correlated with the appearance of regional metastases. Decreased expression of claudin-1 was observed in squamous cell carcinoma of the skin and actinic keratosis compared with normal skin, complete disappearance of expression was observed in squamous cell carcinoma of the oral mucosa compared with leukoplakia. The role of claudin-1 in the growth of benign and malignant skin tumors is not fully understood.

OBJECTIVE

Study of the expression of claudin-1 in epithelial skin tumor cells.

MATERIALS AND METHODS

Immunohistochemical study according to the standard protocol with antibodies to claudin-1 from biopsy material of 51 epithelial skin tumors.

RESULTS

Half of the cells of squamous and basal cell carcinomas of the skin abnormally expressed claudin-1: in the former, the absence of immunoreactivity was significantly more frequent, in the latter, expression in the cytoplasm; in the cell complexes, a chaotic distribution of cells with different types of immunoreactivity was observed. In the cells of actinic keratosis, seborrheic keratosis, and interning follicular keratosis, membrane expression of claudin-1 was statistically significantly predominant, and the zoning of the distribution of immunoreactivity was similar to the normal epidermis.

CONCLUSION

In cells of malignant epithelial skin tumors, pathological expression of claudin-1 prevailed: expression in the cytoplasm in basal cell carcinoma and lack of immunoreactivity in squamous cell carcinoma. In the cells of AK, SK, and IPK, predominantly membrane expression of claudin-1 and a clear zoning of the distribution of cells expressing the marker were observed.

Keywords:

claudin-1

membrane expression

cytoplasmic expression

squamous cell carcinoma

basal cell carcinoma

actinic keratosis

seborrheic keratosis

Authors:

Khlebnikova A.N.

M.F. Vladimirsky Moscow Regional Research Clinical Institute

Scopus AuthorID: 6507373964
ORCID: 0000-0003-4400-5631

Sedova T.G.

E.A. Vagner Perm State Medical University

ORCID: 0000-0002-2660-0536

Gurevich L.E.

M.F. Vladimirsky Moscow Regional Research and Clinical Institute

Selezneva E.V.

M.F. Vladimirsky Moscow Regional Research and Clinical Institute

ORCID: 0000-0002-6181-9031

Molochkov A.V.

M.F. Vladimirsky Moscow Regional Research Clinical Institute;
Peoples’ Friendship University of Russia

Received:

16.05.2020

Accepted:

20.11.2020

Close metadata

References:

Yeatman JM, Kilkenny M, Marks R. The prevalence of seborrhoeic keratoses in an Australian population: does exposure to sunlight play a part in their frequency? Br J Dermatol. 1997;137(3):411-414.
Key statistics for basal and squamous cell skin cancers. American Cancer Society. Available at. May 10, 2016; Accessed: February 27, 2017. https://www.cancer.org/cancer/skincancer-basalandsquamouscell/detailedguide/skin-cancer-basal-and-squamous-cell-key-statistics
Lai V, Cranwell W, Sinclair R. Epidemiology of skin cancer in the mature patuent. Clin Dermatol. 2018;36(2):167-176. https://doi.org/10.1016/j.clindermatol.2017.10.008
Krause G, Winkler L, Mueller SL, Haseloff RF, Piontek J, Blasig IE. Structure and function of claudins. Biochimica et Biophysica Acta. 2008;1778:631-645. https://doi.org/10.1016/j.bbamem.2007.10.018
Morita K, Miyachi Y, Furuse M. Tight junctions in epidermis: from barrier to Keratinization. Eur J Dermatol. 2011;21(1):12-17. https://doi.org/10.1684/ejd.2010.1192
Furuse M, Hata M, Furuse K, Yoshida Y, Haratake A, Sugitani Y, Noda T, Kubo A, Tsukita S. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1 deficient mice. J Cell Biol. 2002;156:1099-1111. https://doi.org/10.1083/jcb.200110122
Arabzadeh A, Troy T-C, Turksen K. Role of the Cldn6 cytoplasmic tail domain in membrane targeting and epidermal differentiation in vivo. Mol Cell Biol. 2006;26:5876-5887. https://doi.org/10.1128/MCB.02342-05
Hadj-Rabia S, Baala L, Vabres P, Hamel-Teillac D, Jacquemin E, Fabre M, Lyonnet S, De Prost Y, Munnich A, Hadchouel M, Smahi A. Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: a tight junction disease. Gastroenterology. 2004;127:1386-1390.
Morita K, Tsukita S, Miyachi Y. Tight junction-associated proteins (occludin, ZO-1, claudin-1, claudin-4) in squamous cell carcinoma and Bowen’s disease. Br J Dermatol. 2004;151:328-334. https://doi.org/10.1111/j.1365-2133.2004.06029.x
Peltonen S, Riehokainen J, Pummi K, Peltonen J. Tight junction components occludin, ZO-1, and claudin-1, -4 and -5 in active and healing psoriasis. Br J Dermatol. 2007;156:466-472. https://doi.org/10.1111/j.1365-2133.2006.07642.x
Arabzadeh A, Troy T-C, Turksen K. Changes in the distribution pattern of Claudin tight junction proteins during the progression of mouse skin tumorigenesis. BMC Cancer. 2007;7:196-203. https://doi.org/10.1186/1471-2407-7-196
Hintsala H-R, Siponen M, Haapasaari K-M, Karihtala P, Soini Y. Claudins 1, 2, 3, 4, 5 and 7 in solar keratosis and squamocellular carcinoma of the skin. Int J Clin Exp Pathol. 2013;6(12):2855-2863.
Katushkina AA, Koviazin VA, Babichenko II. Claudin 1 and Ki67 expression in oral leukoplakia and oral squamous cell carcinoma. Vestnik RUDN, Medicina. 2010;3:94-97. (In Russ.).
Rankie EA, Mu D. Tight Junction Proteins: From Barrier to Tumorigenesis. Cancer Lett. 2014;337(1):41-48. https://doi.org/10.1016/j.canlet.2013.05.038
Hahn-Stromberg V, Askari S, Ahmad A, Befekadu R, Nilsson TK. Expression of claudin 1, claudin 4, and claudin 7 in colorectal cancer and its relation with CLDN DNA methylation patterns. Tumor Biol. 2017;39(4):1-10. https://doi.org/10.1177/1010428317697569
Jang L, Yang L, Huang H, Liu BY, Zu G. Prognostic and clinical significance of claudin-1 in colorectal cancer: A systemic review and meta-analysis. J Surg. 2017;39:214-220. https://doi.org/10.1016/j.ijsu.2017.02.005
Ma F, Ding X, Fan Y, Ying J, Zheng S, Lu N, Xu B. A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer. PloS One. 2014;9(11):e112765. https://doi.org/10.1371/journal.pone.0112765
Vicente DE, Fernandez-Valle A, Vivanco-Alende B, Santamarta TR, Lequerica-Fernandez P, Hernandez-Vallejo G, Alonca-Campa E. The prognostic role of claudins -1 and -4 in oral squamous cell carcinoma. Anticancer Res. 2015;35(5):2949-2959.
Lee JW, Lee SJ, Seo J, Song SY, Ahn G, Park CS, Lee JH, Kim BG, Bae DS. Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia. Gynecol Oncol. 2005;97(1):53-59. https://doi.org/10.1016/j.ygyno.2004.11.058
Hoellen F, Waldmann A, Banz-Jansen C, Holtrich U et al. Claudin-1 expression in cervical cancer. Mol Clin Oncl. 2017;7(5):880-884. https://doi.org/10.3892/mco.2017.1391
Chao YC, Pan SH, Yang SC, Yu SL, Che TF, Lin CW, Tsai MS, Chang GC, Wu CH, Wu YY, Lee YC, Hong TM, Yang PC. Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma. Am J Respir Crit Care Med. 2009;79:123-133. https://doi.org/10.1164/rccm.200803-456OC
Dhawan P, Singh AB, Deane NG, Shiou SR, Schmidt C, Beauchamp RD. Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest. 2005;115:1765-1776. https://doi.org/10.1172/JCI24543
Ouban A, Hamdam H, Hakam A, Ahmed AA. Claudin-1 expression in squamous cell carcinomas of different organs: comparative study of cancerous tissues and normal controls. Int J Surg Pathol. 2012;20(2):132-138. https://doi.org/10.1177/1066896911424488
French AD, Fiori JL, Camilli TC, Leotlela PD, O’Connell MP, Frank BP, Subaran S, Indig FE, Taub DD, Weeraratna AT. PKC and PKA phosphorylation affect the subcellular localization of claudin-1 in melanoma cells. Int J Med Sci. 2009;6:93-101.
Lee JW, Hsiao WT, Chen HY, Hsu LP, Chen PR, Lin MD, Chiu SJ, Shih WL, Hsu YC. Upregulated claudin-1 expression confers resistance to cell death of nasopharyngeal carcinoma cells. Int J Cancer. 2010;126:1353-1366. https://doi.org/10.1002/ijc.24857
Islas S, Vega J, Ponce L, Gonz´alez-Mariscal L. Nuclear localization of the tight junction protein ZO-2 in epithelial cells. Exp Cell Res. 2002;274:138-148. https://doi.org/10.1006/excr.2001.5457
Lee JS, Park HS, Yoon HS, Cho S. Claudin-1 expression decreases with increasing pathological grade in actinic keratosis and may be a marker of high-risk actinic keratosis. Clin Exp Dermatol. 2018, oct. 12. 44(5):483-490. https://doi.org/10.1111/ced.13810